Emergency treatment of anaphylaxis: concise clinical guidance
- PMID: 35882481
- PMCID: PMC9345203
- DOI: 10.7861/clinmed.2022-0073
Emergency treatment of anaphylaxis: concise clinical guidance
Abstract
Anaphylaxis is a serious systemic hypersensitivity reaction that is usually rapid in onset and may cause death. It is characterised by the rapid development of airway and/or breathing and/or circulation problems. Intramuscular adrenaline is the most important treatment, although, even in healthcare settings, many patients do not receive this intervention contrary to guidelines. The Resuscitation Council UK published an updated guideline in 2021 with some significant changes in recognition, management, observation and follow-up of patients with anaphylaxis. This is a concise version of the updated guideline.
Keywords: adrenaline; anaphylaxis; antihistamine; corticosteroids; resuscitation.
© Royal College of Physicians 2022. All rights reserved.
Figures
References
-
- Resuscitation Council UK . Emergency treatment of anaphylaxis: Guidelines for healthcare providers. RCUK, 2021. www.resus.org.uk/library/additional-guidance/guidance-anaphylaxis/emerge... [Accessed on 13 February 2022].
-
- Lieberman P, Nicklas RA, Oppenheimer J, et al. . The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010;126:477–80.e1-42. - PubMed
-
- Panesar SS, Javad S, de Silva D, et al. . The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013;68:1353–61. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
